| RUCAPARIB CAMSYLATE | None | ||
| 200MG, 300MG, 250MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| RUBRACA is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated: Ovarian cancer • for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. Prostate cancer • for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. Select patients for therapy based on an FDA-approved companion diagnostic for RUBRACA. | |||
|
Yes
| |||
| RUBRACA | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||
| *** ****** ****** ********** *** *** ********* ** ****** | *** ****** ****** ********** *** ********* ** ****** | ***** *** ********** ** *-******-*-{*-[(***********)******]******}-*,*,*,*-**********-**-*******[*,*,*-**]*****-*-*** | *** ** **** ********** **** ******** *** *** *********** ** * ********** *** *** ********* ** ****** | ***** *** ********** ** *-******-*-{*-[(***********)******]******}-*,*,*,*-**********-**-*******[*,*,*-**]*****-*-*** | ***** *** ********** ** *-******-*-{*-[(***********)******]******}-*,*,*,*-**********-**-*******[*,*,*-**]*****-*-*** | **** ****** ******** ******* ** ********* | **** ****** ******** ******* ** ********* | ***** *** ********** ** *-******-*-{*-[(***********)******]******}-*,*,*,*-**********-**-*******[*,*,*-**]*****-*-*** | ********* ********** ** ****(***-******) *********** | *********** ********* | *********** ********* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|